DENTSPLY SIRONA Stock Price Jumps 13.3% After Analyst Upgrade

Shares of the medical instruments supplier rise following a price target increase from Robert W. Baird.

Feb. 27, 2026 at 4:19pm

Got story updates? Submit your updates here. ›

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) jumped 13.3% on Friday after investment firm Robert W. Baird raised its price target on the stock from $12.00 to $14.00. Baird maintained its neutral rating on the company. The stock traded as high as $14.48 and closed at $14.41, up from the previous close of $12.71.

Why it matters

The analyst upgrade and resulting stock price increase come as DENTSPLY SIRONA continues to navigate a challenging market environment. The company has faced headwinds such as lower-than-expected revenue guidance for fiscal year 2026, as well as a Q4 net loss driven by goodwill and intangible asset impairments. The positive market reaction suggests investors are optimistic about the company's long-term prospects despite these near-term challenges.

The details

In its research report, Robert W. Baird cited DENTSPLY SIRONA's recent strategic moves, including a "Return-to-Growth" plan that redirects $120 million annually into R&D, clinical education, and sales, as well as a shift in capital allocation toward debt reduction and share repurchases. The firm also noted the company's recent governance and commercial actions, such as three new board appointments and the launch of a new product.

  • DENTSPLY SIRONA stock closed at $12.71 on the previous trading day.
  • On Friday, the stock price rose as high as $14.48 before closing at $14.41, up 13.3% from the previous close.

The players

DENTSPLY SIRONA Inc.

A leading global manufacturer of professional dental products and technologies, headquartered in Charlotte, North Carolina.

Robert W. Baird

An investment firm that raised its price target on DENTSPLY SIRONA from $12.00 to $14.00 while maintaining a neutral rating on the stock.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

The positive market reaction to the analyst upgrade suggests investors see potential in DENTSPLY SIRONA's strategic initiatives, despite the company's recent challenges. However, the stock's performance will likely continue to be influenced by factors such as the company's ability to execute on its growth plans and address any lingering operational or financial headwinds.